Search Results 1241-1250 of 17823 for monoclonal antibody

1. A Study of CMB305 and Atezolizumab in Patients with Sarcoma - Mayo Clinic

   ... monoclonal antibodies, fusion proteins, or CHO cell products. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team ...

2. A Study of Atezolizumab Alone or Combined with Immunomodulatory Drug and/or Daratumumab in Multiple Myeloma Patients - Mayo Clinic

   Receipt of ≥ 2 prior lines of therapy and progressed on treatment with an anti-CD38 monoclonal antibody (Cohort D3). Receipt of ≥ 4 lines of prior therapy ...

3. Translational Science - 2020 Archives - Mayo Clinic News Network

   Convalescent Plasma: A Therapy for COVID-19? Kate Ledger. April 6, 2020. Science Saturday: The importance of antibody testing in addressing COVID-19 featured ...

4. Phase 1/2, Open Label, Dose Escalation Study of NEOD001 in Subjects With Light Chain (AL) Amyloidosis - Mayo Clinic

   Hypersensitivities to other monoclonal antibodies;; Known HIV infection;; Women who are lactating;; Any other condition or prior therapy, which in the opinion ...

5. A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis - Mayo Clinic

   Note: Subjects with antibodies to HBsAg ... Hypersensitivity: Subjects with a known allergy or intolerance to a monoclonal antibody or biologic therapy.

6. Study To Evaluate The Efficacy And Safety Of MEDI9929 (AMG 157) In Adult Subjects With Inadequately Controlled, Severe Asthma - Mayo Clinic

   ... monoclonal antibody specific for the epithelial-cell-derived cytokine thymic stromal lymphopoietin (TSLP), in patients whose asthma remained uncontrolled ...

7. Model Clarifies Immunotherapy for Multiple Myeloma - Mayo Clinic News Network

   The authors report that the mouse model helped evaluate different ways to combine standard chemotherapies with the antibody drugs. They evaluated toxicity ...

8. Study of Safety of Foradil in Patients with Persistent Asthma - Mayo Clinic

   Use of anti-IgE (e.g., omalizumab) or any other monoclonal antibody, in the 6 months prior to randomization. Use of (Beta) β-blockers within 1 day prior to ...

9. Phase 1a/​1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants With Relapsed, Refractory, or Newly Diagnosed Cancers - Mayo Clinic

   * Treatment with a monoclonal antibody, or any other anticancer agent (including biologic, experimental, or hormonal therapy) investigational or otherwise ...

10. Safety and Efficacy of GS-5745 in Participants With Moderately to Severely Active Crohn's Disease - Mayo Clinic

    Treatment with any monoclonal antibody within 4 weeks of screening; History or evidence of colonic mucosal dysplasia; HIV, hepatitis B, hepatitis C, or ...